Kevin Bender is professor of neurology at the University of California, San Francisco. His lab focuses on understanding how the brain encodes information at the synaptic, cellular and network level. Work primarily revolves around understanding how ion channels and modulation of ion channels contribute to these processes in health and in neurodevelopmental and neuropsychiatric conditions. This includes studies related to neurodevelopmental channelopathies, for which he is grateful to be able to work with close colleagues and partners from academia, industry and patient advocacy groups.
Kevin Bender
Professor of neurology
University of California, San Francisco
From this contributor
Should I work with these people? A guide to collaboration
By
Kevin Bender
10 September 2024 | 7 min read
Selected articles
- “Impaired cerebellar plasticity hypersensitizes sensory reflexes in SCN2A-associated ASD” | Neuron
- “Physical and functional convergence of the autism risk genes Scn2a and Ank2 in neocortical pyramidal cell dendrites” | Neuron
- “Arrestin-3 Agonism at Dopamine D3 Receptors Defines a Subclass of Second-Generation Antipsychotics That Promotes Drug Tolerance” | Biological Psychiatry
- “The Autism-Associated Gene Scn2a Contributes to Dendritic Excitability and Synaptic Function in the Prefrontal Cortex” | Neuron
- “Periadolescent Maturation of GABAergic Hyperpolarization at the Axon Initial Segment” | Cell Reports
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read